nivolumab (Opdivo®)
HSE100046
25036
nivolumab
Opdivo®
Bristol-Myers Squibb Pharma EEIG
30/05/2025
26/05/2025
Awaiting Proposal from Applicant
31/07/2025
Applicant Meeting Held with CPU
31/07/2025
Rapid Review Completed
18/06/2025
Pricing and Reimbursement Application Complete
30/05/2025
Rapid Review Commissioned
19/05/2025